drugset / Trial / NCT00446186
MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)
RandomizedParallel-groupDouble-blindTreatment
Summary
The clinical study evaluates the efficacy and safety of MK0476 in adult patients with allergic rhinitis.
Timeline
- Start
- 2004-02
- Primary completion
- 2004-03
- Completion
- 2004-03
Publications
- Results Okubo K, Baba K. A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis. Allergol Int. 2008 Dec;57(4):383-90. doi: 10.2332/allergolint.O-08-533. Epub 2008 Nov 1.
- Results Okubo K, Baba K. Therapeutic effect of montelukast, a cysteinyl leukotriene receptor 1 antagonist, on Japanese patients with seasonal allergic rhinitis. Allergol Int. 2008 Sep;57(3):247-55. doi: 10.2332/allergolint.O-07-515. Epub 2008 Jul 1.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 5 mg | Oral |
| Subject | Montelukast | Other / unclassified | 10 mg | Oral |